Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review

AIMS: Rising prevalence of non-communicable diseases world-wide has made diabetes an important comorbidity in patients with coronavirus disease-19 (COVID-19). We sought to review the risk, severity and mortality in COVID-19 and its relation to the glycemic control, and role of anti-diabetic agents i...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286824/
https://www.ncbi.nlm.nih.gov/pubmed/32533989
http://dx.doi.org/10.1016/j.diabres.2020.108266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286824/
https://www.ncbi.nlm.nih.gov/pubmed/32533989
http://dx.doi.org/10.1016/j.diabres.2020.108266

Ejemplares similares